Dare Bioscience Q3 EPS $(0.2) Misses $(0.16) Estimate

Dare Bioscience (NASDAQ:DARE) reported quarterly losses of $(0.2) per share which missed the analyst consensus estimate of $(0.16) by 25 percent. This is a 13.04 percent increase over losses of $(0.23) per share from the

Benzinga · 11/14/2019 13:12

Dare Bioscience (NASDAQ:DARE) reported quarterly losses of $(0.2) per share which missed the analyst consensus estimate of $(0.16) by 25 percent. This is a 13.04 percent increase over losses of $(0.23) per share from the same period last year.